Barclays Maintains an 'Overweight' on MedAssets (MDAS); Where from Here? First Take and Additional Details after Q4
Tweet Send to a Friend
Barclays maintains an 'Overweight' on MedAssets (NASDAQ: MDAS), PT $22.
Barclays analyst says, "MedAssets Q4 results reported last Thursday, February ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "MedAssets Q4 results reported last Thursday, February ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
